A study was carried out to investigate whether an imbalance in the autonomic nervous system or release of histamine, or both, is responsible for the nocturnal increase in airflow obstruction in asthmatic children. The study comprised 18 children with allergic asthma, nine with (group 1) and nine without (group 2) nocturnal airflow obstruction, and an age matched control group. All drugs were withheld for three days before and during the study. On day 4 each child was admitted to hospital and a series of measurements was made every four hours for 24 hours. These included measurements of the forced expiratory volume in one second (FEVy), heart rate and sinus arrhythmia gap from an electrocardiogram (an indirect measure of parasympathetic activity) and urine sampling for determination of catecholamine and NT-methylhistamine concentrations (measures of sympathetic activity and histamine release respectively). Urinary N?-methylhistamine excretion was significantly higher over the 24 hours in children in group 1 than in children in group 2, and overnight values were also significantly higher in children in group 1 than those in group 2.
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Mean (SEM) values (pmollmol creatinine) were 154-6 (11-2) in group 1 and 110 in group 2 for 2400-0400 hours samples and 139-2 (13-1) and 101-2 (10-6) 0400-0800 hours samples. There was no evidence of decreased sympathetic or increased parasympathetic activity in association with the nocturnal airflow obstruction; noradrenaline concentrations were increased in group 1. These observations indicate that nocturnal airflow obstruction is associated with increased release of histamine overnight.
Nocturnal and early morning dyspnoea are common symptoms in adults and children with asthma and are associated with obstruction of airflow.'2 The increased nocturnal airflow obstruction is thought to be the result of an amplification of the normal circadian rhythm of pulmonary function. 3 One of the causes of noctumal and early morning dyspnoea might be an imbalance in the autonomic regulation of bronchial smooth muscle. An increase in parasympathetic tone, mediated by the vagus nerve, would cause contraction of bronchial smooth muscle and increased mucus secretion. Circulating catecholamines cause bronchodilatation by stimulating the bronchial smooth muscle ,B2 receptor adenylate cyclase complex. They can also inhibit release of mediators from different cell types, such as mast cells, and in this way may provide additional protection against airflow obstruction. 4 Inflammation may also play an important part in nocturnal airflow obstruction, as suggested by Kraan et al,5 who reported that four weeks of treatment with the inhaled corticosteroid budesonide resulted in decreased diurnal variation in peak expiratory flow and in bronchial responsiveness in young adults with asthma.
In the present study, which supplements previous work,6 we investigated circadian variations in airflow obstruction, the balance of the autonomic nervous system, and histamine excretion in children with allergic asthma with and without nocturnal airflow obstruction and compared them with measurements in healthy children matched for age.
Methods

PATIENTS
Asthmatic children from the paediatric asthma outpatient clinic selected to participate in the study were asked to stop taking all prophylactic drugs and bronchodilators for three days before admission. The children were assigned to two groups on the basis of peak expiratory flow measurements (best of three) performed every four hours during three days at home. Selection criteria were as follows: 1 an internal standard. This procedure resulted in a coefficient of variation of 2% for noradrenaline and of4-6% for adrenaline (n = 10).
N -methylhistamine assay
The concentration of N -methylhistamine, an excretion product of endogenously produced histamine, was determined in the same urine samples by isotope dilution mass spectrometry.'01' On the day before the study and during the study the participants avoided food known or suspected to contain histamine. All samples from each subject were analysed together, a blinded procedure being used. (table 2) . Heart rate and sinus arrhythmia gap values differed significantly among the three groups (F = 5-223, df = 2, p = 0-006 and F = 6-227, df = 2, p = 0-003, respectively). Children in group and control children had higher heart Table 2 Mean (SEM) heart rate (beats/min) and sinus arrhythmia gap (beats/min) in children with nocturnal asthma (group 1), those without nocturnal asthma (group 2), and controls over 24 hours on day 4 of study 0800 1200 1600 2000 2400 0400 0800
Heart rate* 800 19 1 (1 4) and 11 9 (1 0) ,umol/mol creatinine (p < 0 01)). Noradrenaline excretion was also higher in those in group 1 in the 2000-2400 hours sample than in controls (17 7 (1 6) ,umol/ mol creatinine (p < 0 05)). There were no significant differences between the values in group 2 and in the control group at any time. No significant correlation between individual FEVy values and urinary adrenaline concentrations was observed (r = 0 20 and 0-02 for groups 1 and 2 respectively).
Urinary Nt-methylhistamine Nt-methylhistamine excretion differed significantly among the groups (p < 0 001), being higher in group 1 than in both group 2 and the control group. It increased overnight in group 1 but showed no variation over the 24 hours in the other two groups (fig 3) . Nt-methylhistamine excretion was higher in group 1 between 2400 and 0800 hours than in group 2 800 (mean (SEM) values for 2400-0400 hours 154-6 (11 2) and 110 pmol/mol creatinine ie for groups 1 and 2 respectively (p < 0-02), and line for 0400-800 hours 139 2 (1341) and 101 2 ontrol (10-6) pmol/mol creatinine (p < 0 05)).
Discussion
In this study we compared results in asthmatic children with and without increased nocturnal airflow obstruction and an age matched control group of non-asthmatic subjects. Children with nocturnal bronchoconstriction had lower baseline FEV, values, higher excretion of Ntmethylhistamine from 2400 to 0800 hours, and higher noradrenaline excretion from 2000 to 0800 hours. Adrenaline excretion was comparable in the three groups. There were no differences in heart rate and sinus arrhythmia gap values among the three groups and hence no evidence of any difference in parasympathetic activity.
The increased urinary concentration of Nmethylhistamine reflected release of histamine, presumably from the lung, in these patients. who observed an increase in plasma histamine concentration during the night. Postma et al 6 observed a slight increase in N t-methylhistamine excretion over 24 hours in nonallergic patients with chronic obstructive lung disease and a fall in FEV, overnight compared with matched controls, but no nocturnal increase. These observations suggest that, at least in chidren and adults with allergic asthma, histamine release contributes to nocturnal airflow obstruction. The release of histamine is probably due to inflammatory changes in the lung occurring at night. The possibility that release ofmediators and inflammation may play a part in nocturnal asthma is supported by studies in which anti-inflammatory treatment showed improvement of nocturnal pulmonary function values and bronchial responsiveness.5 17 18 The reason for the difference in Nt-methyl- Nocturnal and early morning dyspnoea in asthmatic patients is generally thought to be the result of an amplification of the normal circadian rhythm in airflow obstruction.' This amplification may be due to autonomic imbalance, which has been mentioned as a cause of bronchial responsiveness.20 In our study noradrenaline excretion was higher over the 24 hours and overnight in children in group 1 than in those in the other two groups. These raised excretion concentrations were probably a result of the nocturnal bronchoconstriction. Our observations suggest that abnormalities in beta adrenergic control is not of major importance in nocturnal dyspnoea in asthmatic children.
Our data were consistent with those of Barnes et al " in that a significant fall in adrenaline excretion overnight was observed in both asthmatic and normal subjects. In contrast with their study we observed no correlation between FEV, values and urinary catecholamine concentrations at any time.
A nocturnal increase in parasympathetic activity is another possible cause of nocturnal airflow obstruction. Children in group 1 and the control subjects had a higher heart rate and lower sinus arrhythmia gap values than the children in group 2. These observations do not support the hypothesis that increased parasympathetic activity is important in nocturnal airflow obstruction in children with asthma. As heart rate and sinus arrhythmia gap are indirect measures of parasympathetic activity our observations must be interpreted with'c'aution. Failure to observe a change in cardiac vagal activity does not necessarily mean that vagal activity to bronchial smooth muscle is normal. Morrison et al found that intravenous atropine resulted in significant bronchodilatation and an increase in heart rate at 0400 and 1600 hours.2' The decrease in heart rate and increase in sinus arrhythmia gap overnight seen by Postma et al 16 and Kallenbach et al 2 occurred at the same time as the nocturnal airflow obstruction. These observations suggest that parasympathetic activity to the bronchial tree may be reflected by cardiac measures.
The children in our study were woken every four hours, and sleep disruption may have influenced our observations. To investigate whether sleep disruption influenced the degree of nocturnal airflow obstruction Hetzel and Clark22 and Caterall et al2' compared peak expiratory flow values in asthmatic patients after intermittent awakening with values when the patients were kept awake until after the time at which the nocturnal fall in peak expiratory flow rate would have been expected (0300 to 0500 hours). They then slept until 0600 hours. The results of these studies are not conclusive. Disruption of sleep in our stu'dy may have caused a lesser degree of airflow obstruction overnight. This should, however, have affected children in all three groups in our study.
In conclusion, our results suggest that in children with more severe and unstable allergic asthma there is a tendency for urinary histamine secretion to be increased throughout the day and night, but particularly at night. This enhanced secretionmay reflectincreasedinflammatory activity and release of mediators within the airways. Endogenous adrenaline was insufficient to prevent the increase in airflow obstruction ovemight in asthmatic children.
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